Event

Ryan Owen

PhD
Genentech, Inc.

Julie K. Olsson

MD
Genentech, Inc;Genentech, Inc.

Monet Howard

MSc
PRO Unlimited, Inc.

Janusz Kaminski

MD, PhD
Roche Products Ltd

David Kardatzke

PhD
Genentech, Inc.

Lisa Hood. Lancaster

M.D.
Vanderbilt Univ Medical Ctr;Vanderbilt University;Vanderbilt University Medical Center

Marilyn K. Glassberg

MD
University of Miami Health System

Ulrich Costabel

MD
Ruhrlandklinik, University of Duisburg-Essen;University Duisburg-Essen

Yasuhiro Kondoh

M.D., Ph.D.
Tosei Gen Hosp;Tosei General Hospital

Toby M. Maher

MD, MSc, PhD, FRCP
Imperial College;Imperial College London;Imperial College, London;National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Hare;Royal Brompton and Harefield NHS

Paula Belloni

PhD
Genentech, Inc.

Margaret Neighbors

PhD
Genentech, Inc.

Tamera Jo. Corte

MBBS, BScM, PhD
National Health and Medical Research Counsel;Royal Prince Alfred Hospital;Royal Prince Alfred Hospital and University of Sydney;Royal Prince Alfred Hospital; University of Sydney

The RIFF Study (Cohort B): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Lebrikizumab in Combination with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis